ArticleResearch (Washington, D.C.)2026
Mirror-Peptidizer: In Silico Mirror-Image Screening Enables De Novo Design of D-Peptide Binders without D-Protein Synthesis.
Article in Research (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
D-peptides are attractive therapeutic modalities because they are generally more resistant to proteolysis than their L-counterparts, yet systematic design of target-binding D-peptides remains nontrivial. Here, we report Mirror-Peptidizer, an end-to-end in silico mirror-image screening workflow that generates D-peptide binders without requiring chemical synthesis of D-protein targets. The workflow mirrors an L-protein structure to a virtual D-protein, designs L-peptide backbones in the presence of the mirrored target using a diffusion-based backbone generator, selects sequences with a neural sequence design model, and explores local sequence neighborhoods via Bayesian multi-objective optimization balancing sequence-backbone compatibility and a solubility heuristic. Mirroring the resulting complex yields the corresponding D-peptide predicted to bind the native L-target. Using MDM2, PD-L1, and interleukin-23 receptor (IL-23R) as test cases, we identified D-peptides spanning α-helical, β-rich, and mixed conformations with affinity from 11.9 nM to sub-μM. For the MDM2 system, the
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.